Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

Diabetes Management

Cardiometabolic Health Congress (CMHC)

Q&A on Cardiorenal Protection With SGLT-2 Inhibitors in T2DM and Beyond

FEATURING George Bakris, Stephen D. Wiviott, Robert Eckel

238 views
September 22, 2020
2

Cardiometabolic Health Congress (CMHC)

58 y/o Male Treated for Hypertension, Gout, Type 2 Diabetes, and Hypercholesterolemia: What Are the Treatment Strategies for CV and Renal Risk Reduction? SLGT2 Inhibitors Efficacy Review

FEATURING George Bakris, Stephen D. Wiviott, Robert Eckel

301 views
September 22, 2020
1

Cardiometabolic Health Congress (CMHC)

47 y/o Male Referred for Evaluation of Obesity, Type 2 Diabetes & Dyspnea on Exertion: Incorporating SGLT-2 Inhibitors in T2DM for Cardiorenal Protection

FEATURING George Bakris, Stephen D. Wiviott, Robert Eckel

581 views
September 22, 2020
1

Cardiometabolic Health Congress (CMHC)

ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC in HFrEF? What Are the Major Ongoing CKD Trials?

FEATURING Stephen D. Wiviott

376 views
September 22, 2020
3

Cardiometabolic Health Congress (CMHC)

CV Comorbidities in T2DM Patients

142 views
October 22, 2019

Cardiometabolic Health Congress (CMHC)

Review of Recent CVOTs Results and Clinical Implications

FEATURING Lawrence Blonde

16 views
October 22, 2019

Cardiometabolic Health Congress (CMHC)

Individualization of Treatment in T2DM Patients with CVD

FEATURING Harold Bays

528 views
October 22, 2019
5

Cardiometabolic Health Congress (CMHC)

CVOT Data in Your Clinical Practice: Patient Case and Audience Q&A

FEATURING Robert Eckel

29 views
October 22, 2019

Cardiometabolic Health Congress (CMHC)

Identifying Diabetic Kidney Disease in Patients with T2DM: Causes of and Risk Factors

251 views
June 17, 2019
2

Cardiometabolic Health Congress (CMHC)

Navigating the Guidelines for Treatment of T2DM Patients with Diabetic Kidney Disease

145 views
June 17, 2019

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

FEATURING Lance Sloan

8,258 views
June 17, 2019
48

Cardiometabolic Health Congress (CMHC)

Patient Case Study - 68 y.o. Male with Gastroesophageal Reflux Disease (GERD) Symptoms

33 views
June 17, 2019

Cardiometabolic Health Congress (CMHC)

Insulin Therapies of Advances in Insulin Therapy: Addressing Provider and Patient Safety Concerns

FEATURING Anne Louise Peters

219 views
September 3, 2018

Cardiometabolic Health Congress (CMHC)

Pharmacokinetics of Insulin for the Treatment of Diabetes

FEATURING Anne Louise Peters

487 views
September 3, 2018
1

Cardiometabolic Health Congress (CMHC)

Converting to New Basal Insulins and Combination Therapies with Insulin

FEATURING Anne Louise Peters

591 views
September 3, 2018
3

Cardiometabolic Health Congress (CMHC)

Optimizing Insulin Therapy in Type 2 Diabetes

FEATURING Deborah Jane Wexler

246 views
September 3, 2018

Cardiometabolic Health Congress (CMHC)

Applying Insulin Therapy Evidence into Clinical Practice

FEATURING Deborah Jane Wexler

323 views
September 3, 2018
1

Cardiometabolic Health Congress (CMHC)

Q & A: Insulin Therapy in Type 2 Diabetes

FEATURING Deborah Jane Wexler, Anne Louise Peters

19 views
September 3, 2018

Cardiometabolic Health Congress (CMHC)

Reviewing the Cardiovascular Comorbidities in Type 2 Diabetes

FEATURING Jay Skyler

291 views
May 7, 2018

Cardiometabolic Health Congress (CMHC)

Updated Type 2 Diabetes Guidelines

FEATURING Wendy Lane

727 views
May 7, 2018

Cardiometabolic Health Congress (CMHC)

CVOT Trials for Type 2 Diabetes Treatment

FEATURING Robert Eckel

870 views
May 7, 2018
5

Cardiometabolic Health Congress (CMHC)

Interpreting New Antihyperglycemic Agents

FEATURING Benjamin Scirica

545 views
May 7, 2018
1

Cardiometabolic Health Congress (CMHC)

Case Presentation 64 Year Old Type 2 Diabetes and Discussion

FEATURING Wendy Lane

232 views
May 7, 2018